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ABSTRACT Eg5, a member of the bimC subfamily of
kinesin-like microtubule motor proteins, localizes to spindle
microtubules in mitosis but not to interphase microtubules.
We investigated the molecular basis for spindle localization by
transient transfection of Xenopus A6 cells with myc-tagged
derivatives ofEg5. Expressed at constitutively high levels from
a cytomegalovirus promoter, mycEg5 protein is cytoplasmic
throughout interphase, begins to bind microtubules in early
prophase, and remains localized to spindle and/or midbody
microtubules through mitosis to the end of telophase. Both N-
and C-terminal regions of Eg5 are required for this cell-cycle-
regulated targeting. Eg5 also contains within its C-terminal
domain a sequence conserved among bimC subfamily proteins
that includes a potential p34cdc2 phosphorylation site. We
show that mutation of a single threonine (T937) within this
site to nonphosphorylatable alanine abolishes localization of
the mutant protein to the spindle, whereas mutation of T937
to serine preserves spindle localization. We hypothesize that
phosphorylation of Eg5 may regulate its localization to the
spindle in the cell cycle.
Microtubule motor proteins, most notably members of the
kinesin gene family (1), have been implicated in various
intracellular processes, including vesicle transport, mitotic
movements, and the organization of microtubule-based struc-
tures (2-6). How specific motor proteins are targeted and/or
regulated to perform specific biological functions remains,
however, largely unknown. Because members of the kinesin
family share common sequences within a conserved motor
domain, or "head," it is presumed that functional specificity is
determined primarily by nonconserved, nonmotor "tail" do-
mains (6). Tail domains could be expected to regulate motor
activity or localization in any number of ways, such as inter-
acting with head domains to effect conformational changes in
protein structure (7, 8), or binding to additional nonmotor
proteins with specific intracellular locations (9, 10); other
mechanisms of regulation are equally possible. Clearly, in
order to understand motor protein function in vivo, a consid-
erable importance is attached to identifying modes of motor
protein regulation and targeting.
We previously demonstrated that the kinesin-like protein
Eg5 of Xenopus laevis (11) is a plus-end-directed microtubule
motor protein in vitro and is required for efficient spindle
formation in an in vitro assembly reaction (12, 13). Relatives of
Eg5 have been identified in a number of different organisms
and, together with Eg5, these genes-bimC in Aspergillus
nidulans (14, 15), cut7 in Schizosaccharomyces pombe (16),
KLP61F in Drosophila melanogaster (17), and CIN8 and KIP1
in Saccharomyces cerevesiae (18, 19)-appear to define a
subfamily of kinesin-like proteins (the "bimC subfamily"). All
are involved in the assembly and/or function of the spindle
and, where determined, spindle-associated in vivo (13, 18, 20).
The bimC-like proteins are thought to be similar in overall
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structure, having an N-terminal motor domain followed by a
region of predicted a-helix and a nonhelical tail domain of yet
unknown function. Within the motor domain, amino acid
sequences ofbimC subfamily proteins are more similar to each
other than to those of other kinesin-like proteins (1). Conser-
vation of amino acid sequence outside the motor domain,
however, is limited to an "40-residue region in the tail domain
that is at least partially conserved in all subfamily members
except CIN8 and KIP1. Heck et al (17) have suggested that this
region, which we shall refer to as the "bimC box," may act as
a functional specificity determinant. The most highly con-
served portion of the bimC box includes the sequence TGX-
TPXK/RR (in Eg5 it is TGTTPQRR), and it has been noted(17) that this sequence could be phosphorylated by a serine(threonine) protein kinase such as the proline-directed
kinase (21) or an ERK-family kinase (22, 23). We have
further noticed that this same sequence also includes the
consensus phosphorylation site for the cell-cycle kinase
p34cdc2 (consensus S/TPXK/R) (24). As yet, however, no
evidence for phosphorylation of the bimC box by any
serine(threonine) protein kinase has been obtained.
To understand the mechanism by which Eg5 and related
proteins work in mitosis, we would like to know (i) how they
localize to the spindle, (ii) with what other spindle components
they interact, and (iii) how their activity is regulated through-
out the cell cycle and through the different stages of mitosis.
Here we address the first of these questions, by mutating
regions of the Eg5 protein that may be involved in targeting it
to the spindle. We have found that elements of both the N- and
C-terminal domains of Eg5 are required for spindle localiza-
tion. Interestingly, a single point mutation in the most con-
served part of the bimC box is able to abolish spindle local-
ization completely, in a manner that is consistent with phos-
phorylation regulating the localization and/or activity of Eg5.
MATERIALS AND METHODS
Plasmid Construction. All constructs (Fig. 1) were made
using the Eg5K2 gene (25), which is >90% identical to the Eg5
gene originally described (now termed Eg5K1; see ref. 11) and
thought to be the result of pseudotetraploidy in Xenopus. A
3.2-kb near-full-length fragment of Eg5K2 was generated by
partial EcoRI digestion of a cDNA clone in Bluescript II KS+.
This fragment does not encode the N-terminal amino acids
MSSQNSFMSSKKDD (the translational start site may be at
either Met) but does encode all remaining residues (15-1067;
our numbering scheme assumes translation initiation at the
first Met; ref. 25). The initial amino acids are dispensable for
motility in vitro (13) as well as for localization in vivo (see
Results). The myc-tagged "near-full-length" plasmid pEM103
was constructed by cloning the 3.2-kb EcoRI fragment into the
EcoRI site of mycHB, a vector derived from pcDNAI con-
taining a cytomegalovirus promoter and an N-terminal c-myc
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FIG. 1. (Upper) Schematic of Eg5 coding sequence. Amino acid residue numbers are shown above, and properties of the coding sequence are
shown below. "TPQR" indicates the potential p34cdc2 phosphorylation site in the C-terminal portion (bimC box; see text) of the conserved bimC
subfamily sequences. The bubble in the predicted a-helix indicates a short region of predicted nonhelix. (Lower) Names of plasmids encoding
mycEg5K2 and various derivatives, the actual residues encoded (the jagged line represents the myc tag), and whether the encoded proteins localize
to the spindle in mitosis (see text and subsequent figures).
epitope (see below). The mycHB plasmid was the gift of P.
Garcia (University of California, San Francisco). The C-
terminal truncation pEM101 was made by cloning the N-
terminal EcoRI fragment of the Eg5K2 cDNA (residues
15-675) into the same site of mycHB. The polypeptide se-
quence upstream of the Eg5K2 coding sequence for both
pEM101 and pEM103 is MTAEQKLISEEDLNGGRVQD-
PLVTAASVLEFR. In addition, pEM101 and pEM108 (see
below) encode the 26 amino acids FCRYPSHWRPLEHAS-
RGPYSIVSPKC at their C termini as a consequence of the
construction. The N-terminal truncation pEM107 was made by
digesting pEM103 with BamHI, which cuts just 5' to the EcoRI
site of mycHB and at residue 319 in the Eg5K2 coding
sequence. The BamHI digest was subsequently treated with
mung-bean nuclease to put the cDNA in frame with the myc
tag upon ligation/recircularization of the plasmid; this was
confirmed by the creation of a new Pvu II site at the joint. The
double N/C-terminal deletion pEM108 was created by remov-
ing the comparable bases from pEM101. The polypeptide
sequence upstream of Eg5K2 coding regions in pEM107 and
pEM108 is MTAEQKLISEEDLNGGRVQ, followed by
Eg5K2 residues 320-1067 (pEM107) and Eg5K2 residues
320-675 (pEM108).
Site-directed mutations at T937 of Eg5K2 were created by
PCR (26), amplifying a region from anAcc I site at residue 922
to a Xho I site 3' to the Eg5K2 coding region. Amplified
fragments were cloned into a Xho I/partial Acc I digest of
pEM103. The nucleotide sequence for residues 936-937 in
pEM103 is ACA ACG. In pEM109 (T937A) it is ACA GCG;
in pEM110 (T937S) it is ACG TCG; and in pEM111 (T937E)
it is ACA GAG. All mutants were confirmed by sequencing
within the amplified region, at which time we discovered that
the sequence of our original Eg5K2 cDNA was different from
the published sequence (25) in four positions. At position 951
we found the codon AGA (Arg) instead ofAAA (Lys); at 963,
AAG (Lys) instead ofAGG (Arg); at 1020, GGC (Gly) instead
of GGG (Gly); and at 1038, GCA (Ala) instead ofGGA (Gly).
The reasons for these small discrepancies are not yet clear.
Given that all of these differences are silent or conservative
and are present in all of our constructs, we do not believe that
this affects our conclusions.
Cell Culture and Transfections. X. laevis A6 cells were
grown on tissue culture dishes in 70% Leibovitz's L-15/15%
fetal calf serum supplemented with penicillin/streptomycin
and glutamine. Cells were grown to subconfluence in 60-mm
plastic dishes and transfected with Qiagen-purified plasmid
DNA using the calcium phosphate method (27), except that
Hanks' balanced salts contained lower NaCl (1x = 100 mM)
to correct for the lower tonicity of Xenopus culture medium.
Fifteen micrograms of plasmid DNA without carrier was used
per 60-mm culture dish. Cells were exposed to calcium phos-
phate/DNA coprecipitate for 5-6 hr and then washed exten-
sively in 0.7x phosphate-buffered saline (PBS; with calcium/
magnesium) before being returned to fresh medium. Glycerol
shock was not advantageous in this instance, for while it
increased transfection effiency about 2- to 3-fold, the percent-
age of mitotic cells 48 hr after transfection (see below) was
considerably reduced.
Immunofluorescence. Individual 60-mm dishes were washed
with calcium/magnesium-free 0.7x PBS 20-24 hr posttrans-
fection, trypsinized, and resuspended in 0.5-1.0 ml of fresh
medium and then plated onto one or two 18-mm square
coverslips that had been previously acid-washed and poly(L-
lysine)-coated, and further coated with Matrigel (Collabora-
tive Research) just before use. Thirty-six to 48 hr posttrans-
fection, coverslips were rinsed in 0.7x PBS and fixed in cold
methanol. Cells were then rinsed in Tris-buffered saline
(TBS)/0.1% Triton X-100 (TBS/TX) and processed for im-
munofluorescence, using a hybridoma supernatant of the
anti-myc antibody 9E10, which recognizes the sequence
EQKLISEEDLN (28). Because nonspecific background stain-
ing by 9E10 was particularly high in A6 cells, the blocking
medium and antibody incubation medium used for 9E10
staining was TBS/TX containing 3% ovalbumin (Sigma grade
V) and 0.5 M NaCl. For all other immunofluorescence the
blocking solution and antibody diluent was TBS/TX/2%
bovine serum albumin. An anti-Eg5 antibody ("AST") was
raised against a glutathione S-transferase fusion protein con-
taining Eg5K2 residues 320-1067 and affinity-purified on the
same protein bound to Affi-Gel-10 (Bio-Rad) after removal of
anti-glutathione S-transferase antibodies as described (29).
AST was used in immunofluorescence experiments at 20jig/ml. The anti-tubulin antibody DMla (Amersham) was
used as directed by the manufacturer. Secondary antibodies
were from Jackson Immunoresearch. Cells were counter-
stained with 1 ,tg of propidium iodide per ml where appro-
priate and mounted in Tris-buffered glycerol containing 1%
phenylene diamine as an anti-fade ingredient.
Cells expressing the mycEg5 proteins were identified by
scanning stained coverslips with a 25 x /0.8 numerical aperture
multi-immersion objective (Zeiss) and a dual-channel fluores-
cein/rhodamine filter set (Chroma Technology, Brattleboro,
VT) mounted on a Photomicroscope III (Zeiss). A typical
transfection of -8 x 105 cells yielded =50-100 that expressed
the mycEg5 construct above background staining and were in
mitosis as judged by propidium iodide staining of chromo-
somes. This reflects a typical transfection efficiency of 1.5-
2.0% and a mitotic index of about 0.5-1.0% under the condi-
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tions of the experiment. In each experiment at least 35 cells
were scored, and in all experiments the localizations described
were observed in 100% of the cells. Z-series optical sections of
representative cells were collected with a Bio-Rad MRC-600
confocal microscope and projected to produce the images
shown in Figs. 2-4.
RESULTS
We previously demonstrated that Eg5 is present in spindles
assembled in vitro in Xenopus egg extracts and is particularly
enriched near spindle poles (13). To investigate possible
cell-cycle regulation of Eg5 localization we examined its
distribution in the Xenopus cell lines A6, XL177, and XTC (30)
by indirect immunofluorescence. The antibody used (see Ma-
terials and Methods) was highly specific for Eg5 on Western
blots of whole-cell lysates made in Laemmli buffer (ref. 13 and
additional data not shown), and the staining patterns observed
were identical in all three cell types; staining in A6 cells is
described further below.
In interphase cells we observed a weak, diffuse cytoplasmic
staining that was only slightly detectable above background(Fig. 2A). However, by early prophase (i.e., prior to nuclear
envelope breakdown and reorganization of the interphase
microtubule array), Eg5 staining appeared very prominently
along microtubules close to the centrosome and to a lesser
extent on more peripheral microtubules (Fig. 2B; see also Fig.
3B). At later stages of mitosis Eg5 was strongly localized to
mitotic spindle microtubules, and this staining persisted
through the end of mitosis, although astral microtubules
FIG. 2. Localization of endogenous Eg5 in Xenopus A6 cells.
Paired images of anti-Eg5 (Left) and anti-tubulin (Right) staining. (A)
Interphase. (B) Prophase. (C) Metaphase. (Bar = 10 gm.)
remained unstained (Fig. 2C). In contrast to our previous
observations of spindles assembled in vitro (13), we did not find
Eg5 to be highly enriched at spindle poles at metaphase,
although a more polar distribution was readily apparent at both
earlier and later stages of mitosis (see Fig. 3). A generally
similar pattern of Eg5 staining has also been described in A6
cells by Houliston et al (25), although they observed a more
polar localization throughout all stages of mitosis.
We expressed a derivative of Eg5 tagged with an N-terminal
c-myc epitope (mycEg5K2/15-1067; Fig. 1) in A6 cells by
transient transfection. Like the endogenous Eg5, the myc-
tagged Eg5 was spindle-associated in mitosis but exclusively
cytoplasmic during interphase, even when expressed at very
high levels (Fig. 3). A fraction of mycEg5K2/15-1067 protein
remained cytoplasmic during mitosis (perhaps as a conse-
quence of saturated binding sites), but this did not have any
obvious ill effects on mitotic progression, as judged by the
relative proportions of late-stage mitotic cells and respreading
sister cells. These results suggest that Eg5 localization to
microtubules is tightly regulated in the cell cycle.
To investigate which domains of Eg5 might be responsible
for regulating its localization, we expressed N- and C-terminal
fragments of Eg5 containing the myc epitope (mycEg5K2/15-
675 and mycEg5K2/320-1067, respectively; see Fig. 1). Both
N- and C-terminal fragments failed to localize to the spindle
in mitosis, as did the double N- and C-terminal truncation
mycEg5K2/320-675 (Fig. 1), although all three proteins were
clearly expressed at high levels. Representative staining (of
mycEg5K2/15-675) is shown in Fig. 4A and B. These results
suggest that both N- and C-terminal regions of Eg5 are
involved in spindle localization.
FIG. 3. Localization of mycEg5K2/15-1067 in transfected A6 cells.
Paired images of anti-myc (Left) and propidium iodide (Right) staining.(A) Interphase. (B) Prophase. (C) Metaphase. (D) Late anaphase.(Bar = 10 /m.)
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FIG. 4. Localization of mycEg5K2 derivatives in transfected A6 cells. Paired images of anti-myc (Left) and propidium iodide (Right) staining(A-D, G, and H) or anti-myc (Left) and anti-tubulin (Right) staining (E and F). Cells in A, C, E, and G are in interphase; cells in B, D, F, and H
are in metaphase. (A and B) mycEg5K2/15-675. (C-F) mycEg5K2/15-1067(T937A). (G and H) mycEg5K2/15-1067(T937S). (Bar = 10 ,um.)
We were also interested in the function of the bimC box
in regulating Eg5 localization and, in particular, whether a
special role might be played by T937 (the third threonine
residue in the sequence TGTTPQRR), which is most likely
to be phosphorylated by p34cdc2 or an ERK kinase. When
T937 was mutated to alanine by site-directed mutagenesis[mycEg5K2/15-1067(T937A); Fig. 1], spindle localization
was completely abolished, and the expressed protein re-
mained in the cytoplasm (Fig. 4 C and D). As with the
truncation mutants, there were no obvious deleterious con-
sequences of mutant expression. Cells expressing the T937A
mutation were observed in all stages of mitosis and displayed
normal interphase and mitotic microtubule arrays when
doubly stained with anti-myc and anti-tubulin antibodies(Fig. 4 E and F). We then mutated T937 to serine, which
might be expected to preserve spindle localization if phos-
phorylation by a serine(threonine) kinase were involved in
localization. The mutant protein mycEg5K2/15-
1067(T937S) (Fig. 1) was cytoplasmic during interphase and
spindle-associated in mitosis, indistinguishable from
mycEg5K2/15-1067 and the endogenous protein (Fig. 4 G
and H). These experiments indicate that T937 is indeed
critical for determining Eg5 localization and further suggest
that localization may be regulated by a serine(threonine)
kinase that modifies T937. As a further test we also mutated
T937 to glutamate, as mutation of threonine or serine to
glutamate can occasionally mimic a phosphorylated residue
without perturbing biological function (ref. 31, but see also
refs. 32-34). The mutant protein mycEg5K2/15-
1067(T937E) (Fig. 1) did not, however, localize to the
spindle but rather behaved identically to the T937A mutant(not shown). Again we did not observe any gross effects on
mitosis, although anecdotally we observed perhaps a higher
proportion of prometaphase cells, which might indicate a
brief pause in mitotic progression.
DISCUSSION
Our results suggest that a discrete switch regulates Eg5 local-
ization during the cell cycle. Endogenous Eg5 in Xenopus A6
cells is bound to microtubules in mitosis but not during
interphase. A similar cell-cycle-dependent microtubule asso-
ciation for Eg5 has been observed by Houliston et aL (25), who
also found that Eg5 may be associated with interphase micro-
tubules during early Xenopus development. The faint staining
seen in interphase A6 cells may indicate that total levels of Eg5
could be somewhat lower in interphase relative to mitosis;
however, we also found that a myc-tagged Eg5 was expressed
at high levels at all stages of the cell cycle and nonetheless
localized to microtubules only in mitosis. We further note that
the localization of Eg5 to prospective spindle poles at
prophase, prior to nuclear envelope breakdown and the reor-
ganization of the interphase microtubules into a bipolar spin-
dle, suggests that Eg5 localization to spindle microtubules is
perhaps likely to be controlled more directly by cell-cycle
regulatory machinery than by binding to other spindle-
Proc. Natl. Acad. Sci. USA 92 (1995)
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associated components. More generally, this polar localization
suggests that microtubule populations within a single cell can
be biochemically and probably dynamically distinct even at the
very earliest stages of mitosis. Such differences, exemplified in
later stages of mitosis by the formation of kinetochore fibers,
are likely to be important in the assembly of the mitotic
spindle.
What can we say about the molecular mechanisms governing
the localization of Eg5? A simple deletion analysis indicates
that both N- and C-terminal regions are required for spindle
localization and microtubule binding in mitosis. While we
previously showed that an N-terminal fragment of Eg5 iden-
tical to that of mycEg5K2/15-675 is able to bind and trans-
locate microtubules in vitro when fused to glutathione S-
transferase and purified from Escherichia coli (13), it may not
be unreasonable to suspect that a similar fragment might not
bind microtubules strongly in the presence of intracellular
concentrations of ATP. However, if this is the case we must
nevertheless explain how the C terminus of Eg5 is involved in
promoting microtubule binding. In contrast to the C terminus
of kinesin, which does localize to microtubules when expressed
independently in mammalian cells (35), the C terminus of Eg5
does not bind microtubules on its own and thus would appear
not to have any distinct "spindle targeting signal" (assuming
the tagged proteins fold properly in vivo). We believe that the
simplest interpretation of our results is that (i) microtubule
binding and spindle localization are indeed mediated directly
through the N-terminal motor domain, but, in addition, (ii) an
intact C terminus, itself incapable of binding microtubules, is
further required for strong microtubule binding in vivo. One
possible explanation for this behavior might be that as yet
unidentified cellular proteins repress the activity of Eg5 in vivo
by binding or modifying its motor domain, while the tail
domain abrogates this inhibition, perhaps in a cell-cycle-
regulated manner. This interpretation implies that conforma-
tional interactions between motor and nonmotor domains of
Eg5 are likely to be essential for proper function in vivo. These
notions are particularly interesting in light of recent experi-
ments suggesting that a likely Eg5 homolog in Drosophila
embryos can be isolated as a homotetramer (36); one could
thus speculate, for example, that Eg5 is functionally active in
vivo only in higher-order structures that require an intact C
terminus for their assembly. We note that neither our present
experiments nor our interpretation of them, however, can
address the question of how Eg5 is enriched at spindle poles or
why Eg5 is not observed on astral microtubules.
Most strikingly, we have further found that at least one of the
critical C-terminal elements governing spindle localization is
T937. Our observation that T937 can be mutated to serine
without effect but not to alanine is consistent with an impor-
tant function for a hydroxyl group at this position. Given its
location in a consensus phosphorylation site for a number of
protein kinases, including the mitotic regulator p34cdc2, it
seems reasonable to hypothesize that the cell-cycle-regulated
localization of Eg5 may in part result from a cell-cycle-
dependent phosphorylation of T937. Recently it has been
shown that a C-terminal, nonmotor, microtubule binding
domain of the kinesin-like kinetochore protein CENP-E may
be regulated through phosphorylation by p34cdc2 (37). While
we do not yet know if Eg5 is indeed phosphorylated in vivo,
future work combining mutant Eg5 proteins with Xenopus egg
extracts should allow for a detailed analysis of Eg5 phosphor-
ylation in the cell cycle as well as the identification of potential
interacting proteins and/or mechanisms that may modify the
localization or activity of Eg5 in vivo.
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